MAGEL2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-09393
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the N terminal region of human MAGEL2 (Q9UJ55.1). Peptide sequence MQGLFYRPQGSSKERRTSSKERRAPSKDRMIFAATFCAPKAVSAARAHLP
Clonality
Polyclonal
Host
Rabbit
Theoretical MW
58 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Scientific Data Images for MAGEL2 Antibody
Western Blot: MAGEL2 Antibody [NBP3-09393]
Western Blot: MAGEL2 Antibody [NBP3-09393] - Western blot analysis using NBP3-09393 on Human A549 as a positive control. Antibody Titration: 0.2-1 ug/mlApplications for MAGEL2 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: MAGEL2
Alternate Names
MAGE-like 2, MAGE-like protein 2, NDNL1, necdin-like protein 1, nM15, protein nM15
Gene Symbol
MAGEL2
Additional MAGEL2 Products
Product Specific Notices for MAGEL2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...